NCT01832675View on ClinicalTrials.gov

Clinical Trial With Bupivacaine Lozenges as Local Anaesthesia Under Upper Gastrointestinal Endoscopy

PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

August 31, 2012

Study Completion Date

January 31, 2013

Conditions
Application Site Discomfort
Interventions
DRUG

Xylocain, cutaneous spray, solution

10 mg lidocaine/spray. The patient will be sprayed three times and get a maximal dose of 30 mg lidocaine just before the examination.

DRUG

Bupivacaine lozenge

25 mg bupivacaine/lozenge. The patient will get one lozenge 10-15 minutes before the examination.

Trial Locations (1)

2650

Kirurgisk Klinik Hvidovre, Hvidovre

All Listed Sponsors
collaborator

Oracain II Aps

UNKNOWN

lead

Ove Andersen

OTHER

NCT01832675 - Clinical Trial With Bupivacaine Lozenges as Local Anaesthesia Under Upper Gastrointestinal Endoscopy | Biotech Hunter | Biotech Hunter